191 related articles for article (PubMed ID: 30372021)
1. Classics in Chemical Neuroscience: Donepezil.
Brewster JT; Dell'Acqua S; Thach DQ; Sessler JL
ACS Chem Neurosci; 2019 Jan; 10(1):155-167. PubMed ID: 30372021
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
[TBL] [Abstract][Full Text] [Related]
5. First Synthesis of Racemic
Guieu B; Lecoutey C; Legay R; Davis A; Sopkova de Oliveira Santos J; Altomare CD; Catto M; Rochais C; Dallemagne P
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375412
[TBL] [Abstract][Full Text] [Related]
6. Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT
Lalut J; Payan H; Davis A; Lecoutey C; Legay R; Sopkova-de Oliveira Santos J; Claeysen S; Dallemagne P; Rochais C
Sci Rep; 2020 Feb; 10(1):3014. PubMed ID: 32080261
[TBL] [Abstract][Full Text] [Related]
7. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
Pachón-Angona I; Refouvelet B; Andrýs R; Martin H; Luzet V; Iriepa I; Moraleda I; Diez-Iriepa D; Oset-Gasque MJ; Marco-Contelles J; Musilek K; Ismaili L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):479-489. PubMed ID: 30712420
[TBL] [Abstract][Full Text] [Related]
8. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
[TBL] [Abstract][Full Text] [Related]
9. Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy.
Perone R; Albertini C; Uliassi E; Di Pietri F; de Sena Murteira Pinheiro P; Petralla S; Rizzardi N; Fato R; Pulkrabkova L; Soukup O; Tramarin A; Bartolini M; Bolognesi ML
ChemMedChem; 2021 Jan; 16(1):187-198. PubMed ID: 32716144
[TBL] [Abstract][Full Text] [Related]
10. New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Zueva I; Dias J; Lushchekina S; Semenov V; Mukhamedyarov M; Pashirova T; Babaev V; Nachon F; Petrova N; Nurullin L; Zakharova L; Ilyin V; Masson P; Petrov K
Neuropharmacology; 2019 Sep; 155():131-141. PubMed ID: 31132435
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
12. Donepezil induces a cholinergic sprouting in basocortical degeneration.
Ginestet L; Ferrario JE; Raisman-Vozari R; Hirsch EC; Debeir T
J Neurochem; 2007 Jul; 102(2):434-40. PubMed ID: 17394553
[TBL] [Abstract][Full Text] [Related]
13. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
Ghosh S; Jana K; Ganguly B
Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
[TBL] [Abstract][Full Text] [Related]
14. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
Sugimoto H
Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
[TBL] [Abstract][Full Text] [Related]
15. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL
Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease.
Sivaraman B; Raji V; Velmurugan BA; Natarajan R
CNS Neurol Disord Drug Targets; 2022; 21(5):427-449. PubMed ID: 34602041
[TBL] [Abstract][Full Text] [Related]
17. Development of new Alzheimer's disease drug candidates using donepezil as a key model.
Eissa KI; Kamel MM; Mohamed LW; Kassab AE
Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200398. PubMed ID: 36149034
[TBL] [Abstract][Full Text] [Related]
18. Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database.
Miles JA; Ng JH; Sreenivas BY; Courageux C; Igert A; Dias J; McGeary RP; Brazzolotto X; Ross BP
Chem Biol Drug Des; 2021 May; 97(5):1048-1058. PubMed ID: 33455074
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
Green KD; Fosso MY; Garneau-Tsodikova S
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544832
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.
Castro A; Martinez A
Mini Rev Med Chem; 2001 Sep; 1(3):267-72. PubMed ID: 12369973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
